{"id":17458,"date":"2023-11-23T10:01:14","date_gmt":"2023-11-23T10:01:14","guid":{"rendered":"https:\/\/apps.nhslothian.scot\/refhelp\/?page_id=17458"},"modified":"2025-01-09T13:27:14","modified_gmt":"2025-01-09T13:27:14","slug":"dmard-monitoring-abnormal-lft","status":"publish","type":"page","link":"https:\/\/apps.nhslothian.scot\/refhelp\/guidelines\/rheumatology-2\/disease-modifying-anti-rheumatic-drugs-dmards\/dmard-monitoring-abnormal-lft\/","title":{"rendered":"DMARD Monitoring Abnormal LFT"},"content":{"rendered":"\n<p>Please refer to the Shared Care agreement for information on individual drug<\/p>\n\n\n\n<p><a href=\"https:\/\/www.formulary.nhs.scot\/east\/help-and-support\/for-healthcare-professionals\/shared-care-of-medicines\/nhs-lothian-shared-care-agreements\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.formulary.nhs.scot\/east\/help-and-support\/for-healthcare-professionals\/shared-care-of-medicines\/nhs-lothian-shared-care-agreements<\/a><\/p>\n\n\n\n<p>Changes in LFTs\/FBC are more commonly seen after a recent dose increase.<\/p>\n\n\n\n<p><strong>M.A &amp; H.B\/S.R 09-01-25<\/strong><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Please refer to the Shared Care agreement for information on individual drug https:\/\/www.formulary.nhs.scot\/east\/help-and-support\/for-healthcare-professionals\/shared-care-of-medicines\/nhs-lothian-shared-care-agreements Changes in LFTs\/FBC are more commonly seen after a recent dose increase. M.A &amp; H.B\/S.R 09-01-25<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":17358,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[1046],"class_list":["post-17458","page","type-page","status-publish","hentry","category-https-apps-nhslothian-scot-refhelp-dmard-monitoring-abnormal-lft"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"rttpg_featured_image_url":null,"rttpg_author":{"display_name":"heatherlevy","author_link":"https:\/\/apps.nhslothian.scot\/refhelp\/author\/heatherlevy\/"},"rttpg_comment":0,"rttpg_category":" <a href=\"https:\/\/apps.nhslothian.scot\/refhelp\/category\/rheumatology\/https-apps-nhslothian-scot-refhelp-disease-modifying-anti-rheumatic-drugs-dmards\/https-apps-nhslothian-scot-refhelp-dmard-monitoring-abnormal-lft\/\" rel=\"tag\">DMARD Monitoring Abnormal LFT<\/a>","rttpg_excerpt":"Please refer to the Shared Care agreement for information on individual drug https:\/\/www.formulary.nhs.scot\/east\/help-and-support\/for-healthcare-professionals\/shared-care-of-medicines\/nhs-lothian-shared-care-agreements Changes in LFTs\/FBC are more commonly seen after a recent dose increase. M.A &amp; H.B\/S.R 09-01-25","_links":{"self":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/17458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/comments?post=17458"}],"version-history":[{"count":3,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/17458\/revisions"}],"predecessor-version":[{"id":22428,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/17458\/revisions\/22428"}],"up":[{"embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/pages\/17358"}],"wp:attachment":[{"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/media?parent=17458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/apps.nhslothian.scot\/refhelp\/wp-json\/wp\/v2\/categories?post=17458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}